Structure and Clinical Relevance of the Epidermal Growth Factor Receptor in Human CancerKUMAR, Amit; PETRI, Edward T; HALMOS, Balazs et al.Journal of clinical oncology. 2008, Vol 26, Num 10, pp 1742-1751, issn 0732-183X, 10 p.Article

Structure and regulation of Src family kinasesBOGGON, Titus J; ECK, Michael J.Oncogene (Basingstoke). 2004, Vol 23, Num 48, pp 7918-7927, issn 0950-9232, 10 p.Article

C-Cadherin ectodomain structure and implications for cell adhesion mechanismsBOGGON, Titus J; MURRAY, John; CHAPPUIS-FLAMENT, Sophie et al.Science (Washington, D.C.). 2002, Vol 296, Num 5571, pp 1308-1313, issn 0036-8075Article

Analysis of the cytoplasmic interaction between polycystin-1 and polycystin-2CASUSCELLI, Jozefina; SCHMIDT, Stefan; DEGRAY, Brenda et al.American journal of physiology. Renal physiology. 2009, Vol 66, Num 5, issn 1931-857X, F1310-F1315Article

Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog. CommentaryBOGGON, Titus J; YIQUN LI; MANLEY, Paul W et al.Blood. 2005, Vol 106, Num 3, pp 996-1002, issn 0006-4971, 8 p.Article

Structural and numerical variation of FLT3/ITD in pediatric AMLMESHINCHI, Soheil; STIREWALT, Derek L; ALONZO, Todd A et al.Blood. 2008, Vol 111, Num 10, pp 4930-4933, issn 0006-4971, 4 p.Article

JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation modelMERCHER, Thomas; WERNIG, Gerlinde; LEE, Benjamin H et al.Blood. 2006, Vol 108, Num 8, pp 2770-2779, issn 0006-4971, 10 p.Article

G-protein signaling through tubby proteinsSANTAGATA, Sandro; BOGGON, Titus J; BAIRD, Cheryl L et al.Science (Washington, D.C.). 2001, Vol 292, Num 5524, pp 2041-2050, issn 0036-8075Article

EGFR mutation and resistance of non-small-cell lung cancer to gefitinibKOBAYASHI, Susumu; BOGGON, Titus J; DAYARAM, Tajhal et al.The New England journal of medicine. 2005, Vol 352, Num 8, pp 786-792, issn 0028-4793, 7 p.Article

EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapyPAEZ, J. Guillermo; JÄNNE, Pasi A; NAOKI, Katsuhiko et al.Science (Washington, D.C.). 2004, Vol 304, Num 5676, pp 1497-1500, issn 0036-8075, 4 p.Article

Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AMLJINGRUI JIANG; GUILLERMO PAEZ, J; FOX, Edward A et al.Blood. 2004, Vol 104, Num 6, pp 1855-1858, issn 0006-4971, 4 p.Article

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerZHENFENG ZHANG; JAE CHEOL LEE; YUN JUNG CHOI et al.Nature genetics. 2012, Vol 44, Num 8, pp 852-860, issn 1061-4036, 9 p.Article

Exome sequencing identifies recurrent somatic RAC1 mutations in melanomaKRAUTHAMMER, Michael; YONGKONG; ARIYAN, Stephan et al.Nature genetics. 2012, Vol 44, Num 9, pp 1006-1014, issn 1061-4036, 9 p.Article

Genetic Abnormalities of the EGFR Pathway in African American Patients With Non-Small-Cell Lung CancerLEIDNER, Rom S; PINGFU FU; HIRSCH, Fred R et al.Journal of clinical oncology. 2009, Vol 27, Num 33, pp 5620-5626, issn 0732-183X, 7 p.Article

Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment StrategiesZHIWEI YU; BOGGON, Titus J; KOBAYASHI, Susumu et al.Cancer research (Baltimore). 2007, Vol 67, Num 21, pp 10417-10427, issn 0008-5472, 11 p.Article